- Home
- KAR vs SUPN Comparison
KAR vs SUPN Comparison
Compare KAR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- SUPN
- Stock Information
- Founded
- KAR 2006
- SUPN 2005
- Country
- KAR United States
- SUPN United States
- Employees
- KAR N/A
- SUPN N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- KAR Consumer Discretionary
- SUPN Health Care
- Exchange
- KAR Nasdaq
- SUPN Nasdaq
- Market Cap
- KAR 2.2B
- SUPN 2.1B
- IPO Year
- KAR 2009
- SUPN 2012
- Fundamental
- Price
- KAR $20.10
- SUPN $37.74
- Analyst Decision
- KAR Buy
- SUPN Hold
- Analyst Count
- KAR 4
- SUPN 1
- Target Price
- KAR $22.00
- SUPN $36.00
- AVG Volume (30 Days)
- KAR 764.1K
- SUPN 376.5K
- Earning Date
- KAR 02-18-2025
- SUPN 02-25-2025
- Dividend Yield
- KAR N/A
- SUPN N/A
- EPS Growth
- KAR N/A
- SUPN 130.79
- EPS
- KAR 0.19
- SUPN 1.07
- Revenue
- KAR $1,687,800,000.00
- SUPN $651,972,000.00
- Revenue This Year
- KAR $5.10
- SUPN $7.82
- Revenue Next Year
- KAR $3.82
- SUPN N/A
- P/E Ratio
- KAR $109.44
- SUPN $35.28
- Revenue Growth
- KAR 3.76
- SUPN 6.79
- 52 Week Low
- KAR $12.86
- SUPN $25.53
- 52 Week High
- KAR $20.85
- SUPN $39.37
- Technical
- Relative Strength Index (RSI)
- KAR 50.67
- SUPN 57.78
- Support Level
- KAR $19.49
- SUPN $36.48
- Resistance Level
- KAR $20.60
- SUPN $38.68
- Average True Range (ATR)
- KAR 0.48
- SUPN 1.06
- MACD
- KAR -0.04
- SUPN 0.09
- Stochastic Oscillator
- KAR 52.14
- SUPN 68.46
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.